QuantumScape CTO Timothy Holme disposes of common shares worth $1M

Reuters04-04
QuantumScape CTO Timothy Holme disposes of common shares worth $1M
  • QuantumScape Chief Technology Officer Timothy Holme sold 127,077 Class A shares on April 2, 2026 at weighted average price USD 6.18.
  • Separate filing line showed sale of 34,254 Class A shares held by Holme 2020 Irrevocable Trust at weighted average price USD 6.18.
  • Holme reported 1,108,182 Class A shares owned directly following transactions.
  • Beneficial ownership also included 7,479,907 Class B shares held directly.
  • Holme 2020 Irrevocable Trust reported 1,381,179 Class B shares following transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. QuantumScape Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001834249-26-000010), on April 03, 2026, and is solely responsible for the information contained therein.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment